Science Explorer Back to mapMap

Most cited papers from PDX Pharmaceuticals (United States)

What are the most cited papers from PDX Pharmaceuticals (United States)?

The most cited paper from PDX Pharmaceuticals (United States) is "Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles" (Jingga Morry, Worapol Ngamcherdtrakul, Wassana Yantasee, 2016), with 335 citations. Next come "Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment" (197) and "Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer" (193).

Showing 44 of 44 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles Jingga Morry, Worapol Ngamcherdtrakul, Wassana Yantasee · Redox Biology Open access 16 Dec 2016 335
2 Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment Moataz M. Reda, Worapol Ngamcherdtrakul, Molly A. Nelson et al. · Nature Communications Open access 23 Jul 2022 197
3 Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer Worapol Ngamcherdtrakul, Jingga Morry, Shenda Gu et al. · Advanced Functional Materials Open access 24 Mar 2015 193
4 Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer Molly A. Nelson, Worapol Ngamcherdtrakul, Shiuh‐Wen Luoh et al. · Cancer and Metastasis Reviews ReviewOpen access 7 May 2021 126
5 Free mate choice enhances conservation breeding in the endangered giant panda Meghan S. Martin‐Wintle, David J. Shepherdson, Guiquan Zhang et al. · Nature Communications Open access 15 Dec 2015 120
6 Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization Simon D. van Haren, David J. Dowling, Willemina Foppen et al. · The Journal of Immunology Open access 29 Oct 2016 102
7 siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion Worapol Ngamcherdtrakul, Wassana Yantasee · Translational research Open access 20 Aug 2019 83
8 In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response Worapol Ngamcherdtrakul, Moataz M. Reda, Molly A. Nelson et al. · Advanced Materials Open access 12 Jun 2021 73
9 PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer Moataz M. Reda, Worapol Ngamcherdtrakul, Shenda Gu et al. · Cancer Letters Open access 26 Sep 2019 73
10 Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis Jingga Morry, Worapol Ngamcherdtrakul, Shenda Gu et al. · Biomaterials Open access 10 Jul 2015 71
11 Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery Worapol Ngamcherdtrakul, Thanapon Sangvanich, Moataz M. Reda et al. · International Journal of Nanomedicine Open access Jul 2018 69
12 Variation in Reproductive Success Across Captive Populations: Methodological Differences, Potential Biases and Opportunities Simon Charles Griffith et al. · Ethology Open access 14 Dec 2016 67
13 Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery Rajesh Salve, Pramod Kumar, Worapol Ngamcherdtrakul et al. · Materials Science and Engineering C 31 Mar 2021 63
14 Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform Jingga Morry, Worapol Ngamcherdtrakul, Shenda Gu et al. · Molecular Cancer Therapeutics Open access 30 Jan 2017 62
15 Statistical analysis of plasma thermograms measured by differential scanning calorimetry Daniel J. Fish, Greg P. Brewood, Jong Sung Kim et al. · Biophysical Chemistry 30 Sep 2010 55
16 Improving the sustainability of ex situ populations with mate choice Meghan S. Martin‐Wintle, Nathan J. P. Wintle, María Díez‐León et al. · Zoo Biology Open access 26 Nov 2018 52
17 Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis Worapol Ngamcherdtrakul, Daniel S. Bejan, William Cruz‐Muñoz et al. · Small Open access 27 Jan 2022 48
18 Developmental stability of foraging behavior: evaluating suitability of captive giant pandas for translocation Ronald R. Swaisgood, Meghan S. Martin‐Wintle, Megan A. Owen et al. · Animal Conservation Open access 16 Apr 2018 47
19 Therapeutic siRNA for drug-resistant HER2-positive breast cancer Shenda Gu, Zhi Hu, Worapol Ngamcherdtrakul et al. · Oncotarget Open access 15 Feb 2016 47
20 Comprehensive Breeding Techniques for the Giant Panda Meghan S. Martin‐Wintle, David C. Kersey, Nathan J. P. Wintle et al. · Advances in experimental medicine and biology Book chapter 2019 42
21 Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targeted therapies and nanomaterials Moataz M. Reda, Alexander F. Bagley, Husam Y. Zaidan et al. · Radiotherapy and Oncology Open access 27 Jun 2020 29
22 Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment Worapol Ngamcherdtrakul, David Jimenez Castro, Shenda Gu et al. · Cancer Treatment Reviews Open access 22 Feb 2016 27
23 Nanotechnology Applications in Breast Cancer Immunotherapy Ruijie Wang, Pramod Kumar, Moataz M. Reda et al. · Small Open access 21 Dec 2023 26
24 Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment Shenda Gu, Worapol Ngamcherdtrakul, Moataz M. Reda et al. · PLoS ONE Open access 7 Jun 2018 25
25 Stereotypic behaviour predicts reproductive performance and litter sex ratio in giant pandas Meghan S. Martin‐Wintle, Megan A. Owen, Nathan J. P. Wintle et al. · Scientific Reports Open access 29 Apr 2020 24
26 Lanthanide-Loaded Nanoparticles as Potential Fluorescent and Mass Probes for High-Content Protein Analysis Worapol Ngamcherdtrakul, Thanapon Sangvanich, Shaun M. Goodyear et al. · Bioengineering Open access 15 Mar 2019 15
27 Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model Worapol Ngamcherdtrakul, Jingga Morry, Thanapon Sangvanich et al. · Scientific Reports Open access 24 Jan 2019 10
28 Safety, tolerability and pharmacokinetic profile of the low-impact ampakine CX717 in young healthy male subjects and elderly healthy male and female subjects Daniel P. Radin, Rok Cerne, Jodi L. Smith et al. · European Journal of Pharmacology Open access 30 Jan 2025 8
29 Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation Kamal Prakash Pandey, Branka Divović, Farjana Rashid et al. · Journal of Pharmacology and Experimental Therapeutics Open access 6 Feb 2023 7
30 VTX‐1463, a novel TLR‐8 agonist, attenuates nasal congestion after ragweed challenge in sensitized beagle dogs Christopher M. Royer, Karin Rudolph, Gregory N. Dietsch et al. · Immunity Inflammation and Disease Open access 7 Dec 2015 7
31 Designing a mate choice program: Tactics trialed and lessons learned with the critically endangered honeycreeper, 'akikiki ( Oreomystis bairdi ) Donald P. Alverson, Meghan S. Martin‐Wintle, Christina T. Hebebrand et al. · Conservation Science and Practice Open access 28 Mar 2023 6
32 Development of novel immunotherapy based on nanoparticle co-delivering PLK1 and PD-L1 inhibitors for lung cancer treatment Moataz M. Reda, Worapol Ngamcherdtrakul, Natnaree Siriwon et al. · Research Square PreprintOpen access 18 Jan 2021 2
33 Blood Lead Levels in Captive Giant Pandas Nathan J. P. Wintle, Meghan S. Martin‐Wintle, Xiaoping Zhou et al. · Bulletin of Environmental Contamination and Toxicology 24 Nov 2017 2
34 A novel TLR-8 agonist attenuates nasal symptoms/congestion in both dog and human allergen challenge studies Edward G. Barrett, Karin Rudolph, Maura Matthews et al. · Journal of Inflammation Open access Aug 2013 2
35 Cancer Nanomedicine: Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer (Adv. Funct. Mater. 18/2015) Worapol Ngamcherdtrakul, Jingga Morry, Shenda Gu et al. · Advanced Functional Materials Open access May 2015 2
36 Social opportunities and mate preference improve breeding success in Caribbean iguanas Jeffrey M. Lemm, Meghan S. Martin‐Wintle · Scientific Reports Open access 27 Nov 2023 1
37 Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis (Small 11/2022) Worapol Ngamcherdtrakul, Daniel S. Bejan, William Cruz‐Muñoz et al. · Small Open access Mar 2022 1
38 Fiber optic-based fluorescence detection system for in vivo studies of exogenous chromophore pharmacokinetics Daniel R. Doiron, J. B. Dunn, W. L. Mitchell et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE Conference paper May 1995 1
39 Platform based Detection Technologies from Micro scale to Nanoscale Vindhya Kundura, Sudhaprasanna Kumar Padigi, Shalini Prasad · MRS Proceedings 2006 1
40 High-Density Wild-Type IL-2 Nanoparticles Preferentially Enhance CD8⁺ T-Cell Expansion and Reprogram the Tumor Microenvironment Ruijie Wang, Pramod Kumar, Noah A Crumrine et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 15 Jul 2026 0
41 Introducing: Resource Review Jill Emery · The Charleston Advisor Jul 2024 0
42 Safe Serum JOSEPH P. CHANDLER · Nature Biotechnology Open access Oct 1988 0
43 Tumor Therapy: In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response (Adv. Mater. 31/2021) Worapol Ngamcherdtrakul, Moataz M. Reda, Molly A. Nelson et al. · Advanced Materials Aug 2021 0
44 20EVALUATING GENETIC CAUSATION AND PERSONALIZED PHARMACOLOGICAL TREATMENT OF AN ULTRA-RARE DISEASE ASSOCIATED WITH DELETION OF CACNG2 Morgan L. Kleiber, Timothy R. Chapman, M.L. Maile et al. · European Neuropsychopharmacology 2019 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.